Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (91-100 of 212) with videos related to

Pageof 22
Sort By:
Clinical Chemistry|June 25, 2005
Congenital analbuminemia attributable to compound heterozygosity for novel mutations in the albumin geneFilomena Campagna, Francesca Fioretti, Marco Burattin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery diseaseMarcello Arca, Beatrice Conti, Anna Montali, et al.
Atherosclerosis|October 17, 2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid contentAlessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
Heart Failure Clinics|November 15, 2021
New Frontiers in the Treatment of Homozygous Familial HypercholesterolemiaArturo Cesaro, Fabio Fimiani, Felice Gragnano, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2005
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaquesAlessio Annovazzi, Elena Bonanno, Marcello Arca, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Heart (British Cardiac Society)|March 15, 2022
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic targetStefania Angela Di Fusco, Marcello Arca, Pietro Scicchitano, et al.
Cardiovascular Therapeutics|January 24, 2020
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide RegistriesFurio Colivicchi, Michele Massimo Gulizia, Marcello Arca, et al.
Frontiers in Neurology|November 18, 2016
A Novel Mutation in <i>ABCA1</i> Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological PresentationMarco Ceccanti, Chiara Cambieri, Vittorio Frasca, et al.
Pageof 22

Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
Clinical Chemistry|June 25, 2005
Congenital analbuminemia attributable to compound heterozygosity for novel mutations in the albumin geneFilomena Campagna, Francesca Fioretti, Marco Burattin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery diseaseMarcello Arca, Beatrice Conti, Anna Montali, et al.
Atherosclerosis|October 17, 2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid contentAlessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
Heart Failure Clinics|November 15, 2021
New Frontiers in the Treatment of Homozygous Familial HypercholesterolemiaArturo Cesaro, Fabio Fimiani, Felice Gragnano, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2005
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaquesAlessio Annovazzi, Elena Bonanno, Marcello Arca, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Heart (British Cardiac Society)|March 15, 2022
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic targetStefania Angela Di Fusco, Marcello Arca, Pietro Scicchitano, et al.
Cardiovascular Therapeutics|January 24, 2020
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide RegistriesFurio Colivicchi, Michele Massimo Gulizia, Marcello Arca, et al.
Frontiers in Neurology|November 18, 2016
A Novel Mutation in <i>ABCA1</i> Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological PresentationMarco Ceccanti, Chiara Cambieri, Vittorio Frasca, et al.
Pageof 22